Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.3.1.97 extracted from

  • Brannigan, J.A.; Smith, B.A.; Yu, Z.; Brzozowski, A.M.; Hodgkinson, M.R.; Maroof, A.; Price, H.P.; Meier, F.; Leatherbarrow, R.J.; Tate, E.W.; Smith, D.F.; Wilkinson, A.J.
    N-Myristoyltransferase from Leishmania donovani: Structural and functional characterisation of a potential drug target for visceral leishmaniasis (2009), J. Mol. Biol., 396, 985-999.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
drug development the enzyme is a potential target for development of therapeutic agents against visceral leishmaniasis Leishmania donovani
drug development the enzyme is a potential target for drug development Leishmania donovani

Cloned(Commentary)

Cloned (Comment) Organism
DNA and amino acid sequence determination and analysis, overexpression of the His-tagged NMT in Escherichia coli strain BL21(DE3) pRareS Leishmania donovani
overexpression in Escherichia coli strain BL21(DE3) Leishmania donovani

Crystallization (Commentary)

Crystallization (Comment) Organism
purified recombinant enzyme in complex with the non-hydrolysable substrate analogue S-(2-oxo)pentadecyl-CoA, X-ray diffraction structure determination and analysis at 1.4 A resolution, molecular replacement method Leishmania donovani
purified recombinant His-tagged NMT in complex with the non-hydrolysable substrate analogue S-(2-oxo)pentadecyl-CoA, hanging drop vapour diffusion method, mixing of 0.00125 ml of protein solution containing 8 mg/ml protein in 50 mM Tris, pH 8.0, 50 mM NaCl , with 0.00125 l of reservoir solution containing 0.6 M lithium chloride, 20% w/v PEG 6000, 4% v/v 1,4-butanediol in 0.5 M sodium citrate, pH 4.0, equilibration against 0.8 ml of reservoir solution, 20°C, X-ray diffraction structure determination and analysis at 1.4 A resolution, molecular replacement Leishmania donovani

Inhibitors

Inhibitors Comment Organism Structure
additional information ligand binding structure-function analysis for drug design, overview Leishmania donovani
S-(2-oxo)pentadecyl-CoA i.e. NHM, a non-hydrolysable myristoyl-CoA analogue, binding structure analysis, overview; i.e. NHM, a non-hydrolysable myristoyl-CoA analogue, binding structure, overview Leishmania donovani

KM Value [mM]

KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
0.00023
-
myristoyl-CoA pH 7.4, 37°C, recombinant enzyme Leishmania donovani
0.0175
-
ARF peptide pH 7.4, 37°C, recombinant enzyme Leishmania donovani

Metals/Ions

Metals/Ions Comment Organism Structure
Mg2+
-
Leishmania donovani

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
tetradecanoyl-CoA + glycylpeptide Leishmania donovani NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a subset of eukaryotic proteins that function in multiple cellular processes, including vesicular protein trafficking and signal transduction CoA + N-tetradecanoylglycylpeptide
-
?
tetradecanoyl-CoA + glycylpeptide Leishmania donovani LV9 NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a subset of eukaryotic proteins that function in multiple cellular processes, including vesicular protein trafficking and signal transduction CoA + N-tetradecanoylglycylpeptide
-
?

Organism

Organism UniProt Comment Textmining
Leishmania donovani D0AB09
-
-
Leishmania donovani LV9 D0AB09
-
-

Purification (Commentary)

Purification (Comment) Organism
recombinant enzyme from Escherichia coli strain BL21(DE3) Leishmania donovani
recombinant His-tagged enzyme from Escherichia coli strain BL21(DE3) pRareS by metal affinity chromatography and gel filtration, removal of the His-tag by cleavage with HRV 3C protease Leishmania donovani

Source Tissue

Source Tissue Comment Organism Textmining
promastigote
-
Leishmania donovani
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information the fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the carboxy-terminal lobe, substrate binding structure, overview Leishmania donovani ?
-
?
additional information the fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the carboxy-terminal lobe, substrate binding structure, overview Leishmania donovani LV9 ?
-
?
myristoyl-CoA + ARF peptide C-terminally biotinylated ARF peptide, i.e. GLYVSRLFNRLFQKK(Biotin)-NH2, substrate binding structures, overview Leishmania donovani CoA + N-myristoyl-ARF peptide
-
?
tetradecanoyl-CoA + GAAPSKIV-NH2 NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a protein. The fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the C-terminal lobe, substrate binding structure, overview Leishmania donovani CoA + N-tetradecanoyl-GAAPSKIV-NH2
-
?
tetradecanoyl-CoA + GAAPSKIV-NH2 NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a protein. The fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the C-terminal lobe, substrate binding structure, overview Leishmania donovani LV9 CoA + N-tetradecanoyl-GAAPSKIV-NH2
-
?
tetradecanoyl-CoA + GLTISKLFRR NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a protein. The fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the C-terminal lobe, substrate binding structure, overview Leishmania donovani CoA + N-tetradecanoyl-GLTISKLFRR
-
?
tetradecanoyl-CoA + GLTISKLFRR NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a protein. The fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the C-terminal lobe, substrate binding structure, overview Leishmania donovani LV9 CoA + N-tetradecanoyl-GLTISKLFRR
-
?
tetradecanoyl-CoA + glycylpeptide NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a subset of eukaryotic proteins that function in multiple cellular processes, including vesicular protein trafficking and signal transduction Leishmania donovani CoA + N-tetradecanoylglycylpeptide
-
?
tetradecanoyl-CoA + glycylpeptide NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a subset of eukaryotic proteins that function in multiple cellular processes, including vesicular protein trafficking and signal transduction Leishmania donovani LV9 CoA + N-tetradecanoylglycylpeptide
-
?
tetradecanoyl-CoA + GLYVSRLFNRLFQKK(biotin) NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a protein. The fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the C-terminal lobe, substrate binding structure, overview Leishmania donovani CoA + N-tetradecanoyl-GLYVSRLFNRLFQKK(biotin)
-
?
tetradecanoyl-CoA + GLYVSRLFNRLFQKK(biotin) NMT catalyses the attachment of the 14C saturated fatty acid, myristate, to the N-terminal glycine residue of a protein. The fatty acyl-CoA is largely buried in the N-terminal lobe, its binding leading to the loosening of a flap, which in unliganded NMT structures, occludes the protein substrate binding site in the C-terminal lobe, substrate binding structure, overview Leishmania donovani LV9 CoA + N-tetradecanoyl-GLYVSRLFNRLFQKK(biotin)
-
?

Synonyms

Synonyms Comment Organism
myristoyl-CoA-protein N-myristoyltransferase
-
Leishmania donovani
N-myristoyltransferase
-
Leishmania donovani
NMT
-
Leishmania donovani

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
37
-
assay at Leishmania donovani

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
7.4
-
assay at Leishmania donovani

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0000687
-
-
Leishmania donovani S-(2-oxo)pentadecyl-CoA
0.0687
-
pH 7.4, 37°C, recombinant enzyme Leishmania donovani S-(2-oxo)pentadecyl-CoA

General Information

General Information Comment Organism
physiological function NMT function is essential for viability in host cells and in insect stages of the pathogenic protozoan parasite Leishmania donovani
physiological function NMT catalyses the attachment of the 14-carbon saturated fatty acid, myristate, to the amino-terminal glycine residue of a subset of eukaryotic proteins that function in multiple cellular processes, including vesicular protein trafficking and signal transduction. In these pathways, N-myristoylation facilitates association of substrate proteins with membranes or the hydrophobic domains of other partner peptides. NMT function is essential for viability in all cell types tested to date Leishmania donovani